Zimbabwe is facing a shortage of critical antiretroviral drugs due to reduced global production and delayed shipments from suppliers due to the global Covid-19 lockdown restrictions. The Ministry of Health and Child Care has since advised that patients on Atazanavir/ritonavir (ATV/r) treatment should be given one month’s supplies until stocks improve. In 2016, MOHCC launched […]